Truist Securities has initiated coverage on Guardian Pharmacy Services (GRDN) with a ‘Buy’ rating and a price target of $22. The firm sees a sizable market opportunity for the company, which operates long-term care pharmacies, citing strong industry trends driven by the aging population and an increase in residents at assisted living facilities. Truist believes Guardian’s differentiated scale, suite of capabilities, and strategic market targeting make it well-positioned for growth.